KYNB
HealthcareKyntra Bio, Inc.
$6.98-0.04 (-0.57%)
Prev Close
$7.02
Open
$7.12
High
$7.26
Low
$6.92
Volume
16.2K
Market Cap
$29.7M
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Kyntra Bio, Inc. (KYNB) has been dominated by buying, with 4 insider purchases totaling $308.9K and 4 insider sales totaling $8.6K. The most recent insider transaction was by DeLucia David (Chief Financial Officer), who sold $437.84 worth of shares on Dec 6, 2025. Kyntra Bio, Inc. operates in the Healthcare sector, within the Medical - Pharmaceuticals industry, with a market cap of $29.7M.
Buys (12M)
4
$308.9K
Sells (12M)
4
$8.6K
Net Activity
Net Buyer
$300.4K
Active Insiders
4
last 12 mo
KYNB Price Chart
KYNB Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 6, 2025↗ | DeLucia David | Chief Financial Officer | Sell | 52 | $8.42 | $437.84 | 0 |
| Dec 6, 2025↗ | Wettig Thane | CEO | Sell | 259 | $8.42 | $2.2K | 0 |
| Nov 13, 2025↗ | Wettig Thane | CEO | Buy | 3,700 | $9.12 | $33.7K | 0 |
| Jun 30, 2025↗ | Schoeneck James A | Director | Buy | 23,567 | $5.07 | $119.5K | 0 |
| Jun 6, 2025↗ | DeLucia David | Chief Financial Officer | Sell | 104 | $10.01 | $1.0K | 0 |
| Jun 6, 2025↗ | Wettig Thane | CEO | Sell | 494 | $9.97 | $4.9K | 0 |
| Mar 24, 2025↗ | Wettig Thane | CEO | Buy | 145,000 | $0.35 | $50.7K | 0 |
| Mar 20, 2025↗ | Schoeneck James A | Director | Buy | 300,000 | $0.35 | $105.0K | 0 |
| Mar 6, 2025↗ | Chung Christine | SVP, CHINA OPERATIONS | Sell | 7,430 | $0.39 | $2.9K | 0 |
| Mar 6, 2025↗ | DeLucia David | Chief Financial Officer | Sell | 2,325 | $0.39 | $906.75 | 0 |
| Mar 6, 2025↗ | Wettig Thane | CEO | Sell | 22,405 | $0.39 | $8.7K | 0 |
| Jun 13, 2024↗ | Adib Deyaa | Chief Medical Officer | Buy | 22,123 | $1.17 | $25.9K | 82,123 |
| Mar 11, 2024↗ | Wettig Thane | CEO | Buy | 50,000 | $1.91 | $95.5K | 470,178 |
| Sep 6, 2023↗ | Henderson Jeffrey William | Director | Sell | 2,000 | $1.03 | $2.1K | 28,866 |
| Aug 8, 2023↗ | Henderson Jeffrey William | Director | Sell | 2,000 | $1.91 | $3.8K | 30,866 |
| Jul 13, 2023↗ | Henderson Jeffrey William | Director | Sell | 2,000 | $2.69 | $5.4K | 32,866 |
| Jul 10, 2023↗ | Conterno Enrique A | Chief Executive Officer | Sell | 1,880 | $2.80 | $5.3K | 374,722 |
| Jun 26, 2023↗ | Wettig Thane | Chief Commercial Officer | Sell | 791 | $16.53 | $13.1K | 108,261 |
| Jun 15, 2023↗ | Chung Christine | SVP, China Operations | Sell | 12,500 | $17.19 | $214.9K | 242,577 |
| Jun 9, 2023↗ | Blaug Suzanne | Director | Sell | 8,520 | $17.20 | $146.6K | 34,763 |
| Jun 9, 2023↗ | Brennan Aoife | Director | Sell | 4,733 | $17.19 | $81.4K | 30,686 |
| Jun 9, 2023↗ | Chung Christine | SVP, China Operations | Sell | 3,633 | $17.04 | $61.9K | 251,098 |
| Jun 9, 2023↗ | Conterno Enrique A | Chief Executive Officer | Sell | 8,897 | $17.04 | $151.6K | 382,708 |
| Jun 9, 2023↗ | Cravatt Benjamin | Director | Sell | 3,944 | $17.17 | $67.7K | 30,914 |
| Jun 9, 2023↗ | EDWARDS JEFFREY L | Director | Sell | 7,889 | $17.19 | $135.6K | 38,601 |
| Jun 9, 2023↗ | Eisner Mark | EVP, Chief Medical Officer | Sell | 2,042 | $17.04 | $34.8K | 162,862 |
| Jun 9, 2023↗ | Graham Juan | Chief Financial Officer | Sell | 1,785 | $16.99 | $30.3K | 71,818 |
| Jun 9, 2023↗ | Henderson Jeffrey William | Director | Sell | 7,000 | $17.46 | $122.2K | 39,860 |
| Jun 9, 2023↗ | Ho Maykin | Director | Sell | 8,520 | $17.44 | $148.6K | 37,726 |
| Jun 9, 2023↗ | Schoeneck James A | Director | Sell | 7,100 | $18.03 | $128.0K | 73,722 |
| Jun 9, 2023↗ | Wettig Thane | Chief Commercial Officer | Sell | 1,758 | $17.04 | $30.0K | 112,681 |
| Jun 5, 2023↗ | Eisner Mark | EVP, Chief Medical Officer | Sell | 1,090 | $18.83 | $20.5K | 164,904 |
| Apr 11, 2023↗ | Conterno Enrique A | Chief Executive Officer | Sell | 1,869 | $19.52 | $36.5K | 382,999 |
| Apr 6, 2023↗ | Chung Christine | SVP, China Operations | Sell | 6,590 | $18.78 | $123.8K | 252,460 |
| Apr 6, 2023↗ | Eisner Mark | Chief Medical Officer | Sell | 9,182 | $18.78 | $172.5K | 165,994 |
| Mar 24, 2023↗ | Wettig Thane | Chief Commercial Officer | Sell | 905 | $18.71 | $16.9K | 110,653 |
| Mar 10, 2023↗ | Chung Christine | SVP, China Operations | Sell | 15,960 | $20.70 | $330.4K | 261,964 |
| Mar 10, 2023↗ | Conterno Enrique A | Chief Executive Officer | Sell | 56,261 | $20.62 | $1.16M | 404,357 |
| Mar 10, 2023↗ | Eisner Mark | Chief Medical Officer | Sell | 17,503 | $20.60 | $360.6K | 181,431 |
| Mar 10, 2023↗ | Graham Juan | Chief Financial Officer | Sell | 7,661 | $20.54 | $157.4K | 76,668 |
| Mar 10, 2023↗ | Wettig Thane | Chief Commercial Officer | Sell | 13,934 | $20.63 | $287.4K | 116,289 |
| Mar 6, 2023↗ | Eisner Mark | Chief Medical Officer | Sell | 1,187 | $21.87 | $26.0K | 172,496 |
| Jan 10, 2023↗ | Conterno Enrique A | Chief Executive Officer | Sell | 1,538 | $19.95 | $30.7K | 295,483 |
| Dec 28, 2022↗ | Wettig Thane | Chief Commercial Officer | Sell | 734 | $15.80 | $11.6K | 89,163 |
| Dec 15, 2022↗ | Graham Juan | Chief Financial Officer | Sell | 5,741 | $14.89 | $85.5K | 50,628 |
| Dec 14, 2022↗ | Graham Juan | Chief Financial Officer | Sell | 2,188 | $14.64 | $32.0K | 55,110 |
| Dec 9, 2022↗ | Chung Christine | SVP, China Operations | Sell | 1,096 | $15.79 | $17.3K | 237,705 |
| Dec 9, 2022↗ | Conterno Enrique A | Chief Executive Officer | Sell | 2,543 | $15.79 | $40.2K | 297,020 |
| Dec 9, 2022↗ | Wettig Thane | Chief Commercial Officer | Sell | 382 | $15.79 | $6.0K | 89,897 |
| Sep 17, 2021↗ | KEARNS THOMAS F JR | Director | Sell | 13,100 | $11.58 | $151.7K | 39,764 |
Showing 1–50 of 53
1 / 2
KYNB Insider Buying Activity
The following table shows recent insider purchases of Kyntra Bio, Inc. (KYNB) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 13, 2025↗ | Wettig Thane | CEO | Buy | 3,700 | $9.12 | $33.7K | 0 |
| Jun 30, 2025↗ | Schoeneck James A | Director | Buy | 23,567 | $5.07 | $119.5K | 0 |
| Mar 24, 2025↗ | Wettig Thane | CEO | Buy | 145,000 | $0.35 | $50.7K | 0 |
| Mar 20, 2025↗ | Schoeneck James A | Director | Buy | 300,000 | $0.35 | $105.0K | 0 |
| Jun 13, 2024↗ | Adib Deyaa | Chief Medical Officer | Buy | 22,123 | $1.17 | $25.9K | 82,123 |
| Mar 11, 2024↗ | Wettig Thane | CEO | Buy | 50,000 | $1.91 | $95.5K | 470,178 |
KYNB Insider Selling Activity
The following table shows recent insider sales of Kyntra Bio, Inc. (KYNB) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 6, 2025↗ | DeLucia David | Chief Financial Officer | Sell | 52 | $8.42 | $437.84 | 0 |
| Dec 6, 2025↗ | Wettig Thane | CEO | Sell | 259 | $8.42 | $2.2K | 0 |
| Jun 6, 2025↗ | DeLucia David | Chief Financial Officer | Sell | 104 | $10.01 | $1.0K | 0 |
| Jun 6, 2025↗ | Wettig Thane | CEO | Sell | 494 | $9.97 | $4.9K | 0 |
| Mar 6, 2025↗ | Chung Christine | SVP, CHINA OPERATIONS | Sell | 7,430 | $0.39 | $2.9K | 0 |
| Mar 6, 2025↗ | DeLucia David | Chief Financial Officer | Sell | 2,325 | $0.39 | $906.75 | 0 |
| Mar 6, 2025↗ | Wettig Thane | CEO | Sell | 22,405 | $0.39 | $8.7K | 0 |
| Sep 6, 2023↗ | Henderson Jeffrey William | Director | Sell | 2,000 | $1.03 | $2.1K | 28,866 |
| Aug 8, 2023↗ | Henderson Jeffrey William | Director | Sell | 2,000 | $1.91 | $3.8K | 30,866 |
| Jul 13, 2023↗ | Henderson Jeffrey William | Director | Sell | 2,000 | $2.69 | $5.4K | 32,866 |
| Jul 10, 2023↗ | Conterno Enrique A | Chief Executive Officer | Sell | 1,880 | $2.80 | $5.3K | 374,722 |
| Jun 26, 2023↗ | Wettig Thane | Chief Commercial Officer | Sell | 791 | $16.53 | $13.1K | 108,261 |
| Jun 15, 2023↗ | Chung Christine | SVP, China Operations | Sell | 12,500 | $17.19 | $214.9K | 242,577 |
| Jun 9, 2023↗ | Blaug Suzanne | Director | Sell | 8,520 | $17.20 | $146.6K | 34,763 |
| Jun 9, 2023↗ | Brennan Aoife | Director | Sell | 4,733 | $17.19 | $81.4K | 30,686 |
| Jun 9, 2023↗ | Chung Christine | SVP, China Operations | Sell | 3,633 | $17.04 | $61.9K | 251,098 |
| Jun 9, 2023↗ | Conterno Enrique A | Chief Executive Officer | Sell | 8,897 | $17.04 | $151.6K | 382,708 |
| Jun 9, 2023↗ | Cravatt Benjamin | Director | Sell | 3,944 | $17.17 | $67.7K | 30,914 |
| Jun 9, 2023↗ | EDWARDS JEFFREY L | Director | Sell | 7,889 | $17.19 | $135.6K | 38,601 |
| Jun 9, 2023↗ | Eisner Mark | EVP, Chief Medical Officer | Sell | 2,042 | $17.04 | $34.8K | 162,862 |
| Jun 9, 2023↗ | Graham Juan | Chief Financial Officer | Sell | 1,785 | $16.99 | $30.3K | 71,818 |
| Jun 9, 2023↗ | Henderson Jeffrey William | Director | Sell | 7,000 | $17.46 | $122.2K | 39,860 |
| Jun 9, 2023↗ | Ho Maykin | Director | Sell | 8,520 | $17.44 | $148.6K | 37,726 |
| Jun 9, 2023↗ | Schoeneck James A | Director | Sell | 7,100 | $18.03 | $128.0K | 73,722 |
| Jun 9, 2023↗ | Wettig Thane | Chief Commercial Officer | Sell | 1,758 | $17.04 | $30.0K | 112,681 |
| Jun 5, 2023↗ | Eisner Mark | EVP, Chief Medical Officer | Sell | 1,090 | $18.83 | $20.5K | 164,904 |
| Apr 11, 2023↗ | Conterno Enrique A | Chief Executive Officer | Sell | 1,869 | $19.52 | $36.5K | 382,999 |
| Apr 6, 2023↗ | Chung Christine | SVP, China Operations | Sell | 6,590 | $18.78 | $123.8K | 252,460 |
| Apr 6, 2023↗ | Eisner Mark | Chief Medical Officer | Sell | 9,182 | $18.78 | $172.5K | 165,994 |
| Mar 24, 2023↗ | Wettig Thane | Chief Commercial Officer | Sell | 905 | $18.71 | $16.9K | 110,653 |
| Mar 10, 2023↗ | Chung Christine | SVP, China Operations | Sell | 15,960 | $20.70 | $330.4K | 261,964 |
| Mar 10, 2023↗ | Conterno Enrique A | Chief Executive Officer | Sell | 56,261 | $20.62 | $1.16M | 404,357 |
| Mar 10, 2023↗ | Eisner Mark | Chief Medical Officer | Sell | 17,503 | $20.60 | $360.6K | 181,431 |
| Mar 10, 2023↗ | Graham Juan | Chief Financial Officer | Sell | 7,661 | $20.54 | $157.4K | 76,668 |
| Mar 10, 2023↗ | Wettig Thane | Chief Commercial Officer | Sell | 13,934 | $20.63 | $287.4K | 116,289 |
| Mar 6, 2023↗ | Eisner Mark | Chief Medical Officer | Sell | 1,187 | $21.87 | $26.0K | 172,496 |
| Jan 10, 2023↗ | Conterno Enrique A | Chief Executive Officer | Sell | 1,538 | $19.95 | $30.7K | 295,483 |
| Dec 28, 2022↗ | Wettig Thane | Chief Commercial Officer | Sell | 734 | $15.80 | $11.6K | 89,163 |
| Dec 15, 2022↗ | Graham Juan | Chief Financial Officer | Sell | 5,741 | $14.89 | $85.5K | 50,628 |
| Dec 14, 2022↗ | Graham Juan | Chief Financial Officer | Sell | 2,188 | $14.64 | $32.0K | 55,110 |
| Dec 9, 2022↗ | Chung Christine | SVP, China Operations | Sell | 1,096 | $15.79 | $17.3K | 237,705 |
| Dec 9, 2022↗ | Conterno Enrique A | Chief Executive Officer | Sell | 2,543 | $15.79 | $40.2K | 297,020 |
| Dec 9, 2022↗ | Wettig Thane | Chief Commercial Officer | Sell | 382 | $15.79 | $6.0K | 89,897 |
| Sep 17, 2021↗ | KEARNS THOMAS F JR | Director | Sell | 13,100 | $11.58 | $151.7K | 39,764 |
KYNB Insiders
Similar Stocks to KYNB
LLY
Eli Lilly and Company
$984.11+0.70%
$921.90B
JNJ
Johnson & Johnson
$241.86-0.07%
$583.29B
ABBV
AbbVie Inc.
$220.81-2.02%
$398.49B
MRK
Merck & Co., Inc.
$115.92+0.00%
$286.57B
UNH
UnitedHealth Group Incorporated
$281.12+1.48%
$251.47B
AMGN
Amgen Inc.
$366.74-0.29%
$198.26B
ABT
Abbott Laboratories
$108.01-0.12%
$187.91B
GILD
Gilead Sciences, Inc.
$144.25-0.66%
$180.27B